
The 10 best FSA-approved foot massagers, according to podiatrists
Investing in the best foot massager isn't just a luxury, but a necessity for maintaining overall podiatric health and daily comfort. And when you have the option of getting some hard-earned cash back from your employer-sponsored flexible spending account, this FSA-eligible expense is a smart step in the right direction.
'Foot massagers are a great way to soothe tired, achy feet and FSA-approved massagers have the added bonus of potentially saving people some of the expense,' says Dr. Michael Nirenberg, a clinical and forensic podiatrist at Friendly Foot Care in Indiana. 'I have seen both FSA and non-FSA foot massagers that are excellent. My feeling is that health care is expensive, and if you can save a little money, go for an FSA-approved foot massager.'
From FSA-approved foot massagers that help boost circulation and eradicate everyday pains to options that simply melt away stress and promote relaxation, here's exactly what to look for and which options to shop for some extra pep in your step.
Caresky Pro Shiatsu Foot Massager
Between its three heat levels, safety timer, numerous massage modes and remote control for ultimate convenience, this FSA-approved foot massager checks off every box. 'I recommend the Caresky Pro Foot Massager,' says Nirenberg says. 'This massager gives a good balance between features and safety. It offers multiple types of massage and heat, and while at first glance it looks bulky, it is not heavy.' The best part? It comfortably fits feet up to size 14.
TheraFlow Small Dual-Foot Massager
If staying pain-free on the road is a priority for you, be sure to grab this compact, expert-approved pick that doesn't require any batteries or charging ports to operate. 'This is a portable, manual option that is great for targeting plantar fasciitis pain and improving circulation,' says Dr. Gregory Alvarez, podiatrist at Ankle & Foot Centers of America.
Cloud Massage Shiatsu Foot Massager
To feel like you're walking on clouds, consider adding this comfortable option to your cart. 'This one offers deep-tissue massage, heat and compression therapy, making it suitable for chronic foot pain and swelling,' Alvarez says.
Bob and Brad Foot Massager
The allure of this FSA-approved foot massager is that it's designed to feel like a lifelike massage that uses hands and fingers to melt away pain and sensitivity. Its remote control further adds to its convenience, while multiple massage modes, heat settings and intensities allow you to walk away feeling lighter and more comfortable in your step.
Renpho Shiatsu Foot Massager With Heat
Alvarez recommends this popular model because 'it combines kneading, rolling and heat functions in a compact design, ideal for stress relief and circulation.' As it focuses predominantly on massaging the arches and heel of the foot — as opposed to the toes — it makes for a solid option for those struggling with plantar fasciitis.
Miko Shiatsu Foot, Calf and Ankle Massager With Heat
Whether you're experiencing swelling, neuropathy or chronic pain, this foot massager with access to your calves provides some much-needed relief with your choice of intensity. 'This massager offers many different options and massage levels for those with sensitive feet,' Nirenberg says. Plus, the included remote allows you to personalize your foot massage, well, remotely.
Tisscare Foot Massager With Heat
This FSA-eligible foot massager combines heat therapy with shiatsu massage to deliver a spa-grade therapeutic experience from the comfort of your favorite chair. It's equipped with five levels of air compression and three massage modes to melt away sore spots. Use the adjustable handle to angle it toward either your feet or your calves for a bespoke massage experience to promote circulation where you need it most.
Tadoune 2-in-1 EMS Foot Massager Mat
For ultimate relief on the go, look no further than this 2-in-1 foot massager mat that doubles as a back massager (it's also suitable for virtually anywhere you can use a little extra TLC). Despite its simple interface, it boasts a whopping eight modes and 19 intensities. Thanks to a 15-minute auto shutoff feature, you can doze off while using it — worry-free.
Yoyomax Electric Foot Massager With Heat and Ice Therapy
Our experts agree the application of heat can do wonders for achy feet, but it can come at the risk of sores and infections, especially for users with diabetes. An alternate option with plenty of restorative benefits is this foot massager boasting a cold therapy component, proven to reduce inflammation and promote recovery.
Fit King Air Massager
This wraparound-style massager uses air compression to deliver a therapeutic massage from the knee all the way down, with two massage modes and three intensity levels. The attached handheld remote means, unlike the others hidden in your couch cushions, it'll never get lost. The massager comes with two calf extensions to fit a wider range of users. Personalized modes
When looking for an FSA-approved foot massager, 'it is best to first think about what you want the massager to do for you and your particular situation,' Nirenberg says. He recommends looking for foot massagers that allow you to alternate between massage types, like shiatsu, kneading and rolling, to suit your needs and comfort level. 'Features vary as well,' he says. 'Do you want vibration, heat or even a remote control if you do not want to have to bend down to operate the device? I know a lot of my older patients simply cannot bend down without difficulty, often due to arthritis, and for them, having a massager with a remote control [is a wise option].'
Alvarez says the foot massager should boast an ergonomic design that caters to different foot sizes so you can be sure it works for you. While FSA-approved foot massagers can indeed be therapeutic from a medical vantage point, he says they are also designed to be a useful tool for relaxation.
Wider massage ranges
According to Nirenberg, our calves play an important role in pumping blood throughout our feet and legs, so a massager that can assist in this function may be a worthy option. 'I try to find foot massagers that not only work on my feet but my calves as well,' Nirenberg says. 'These seem to get the blood moving better.'
Safety features
When heat and pressure are involved, you always want to look for safety features like auto shutoff. 'Another safety feature I like are massagers that can be set to turn off after a period of time automatically,' Nirenberg says. 'This way, if a person falls asleep, the machine will not keep going and lead to an injury.'
FSA eligibility
It may sound obvious, but it's worth the reminder: Before adding to cart, double-check that the foot massager in question is actually eligible for FSA reimbursement. 'Ensure the massager is explicitly labeled as FSA eligible and check the manufacturer's details, or consult your FSA plan administrator for confirmation,' Alvarez says.
Expert consultation
Before investing in an FSA-approved foot massager, speak with your medical provider or podiatrist to confirm whether the device is right for you. 'As an important caution for diabetic patients, those with neuropathy or poor circulation should check with their podiatrist first,' says Nirenberg, adding that some massagers can be quite strong or get very warm, posing a risk of developing sores or infections. 'Over my 30-plus years in practice, I have seen some diabetic patients end up with serious infections and even amputations from heating or massage devices.'
The following FAQs have been answered by podiatrist Gregory Alvarez.
What are the different types of FSA-approved foot massagers?
What are the different types of FSA-approved foot massagers?
FSA-approved foot massagers typically fall into the following categories.
Manual massagers, which are handheld or roller devices that provide customizable pressure.
Electric massagers, which are powered devices with features like vibration, kneading and heat therapy for deeper relaxation and therapeutic benefits.
Compression massagers, which use air pressure to improve circulation and reduce swelling, and is particularly beneficial for those with conditions like edema.
Hydrotherapy massagers, which are foot spas that combine water jets and massage functions for added relief.How do I use FSA dollars on an FSA-approved foot massager?
How do I use FSA dollars on an FSA-approved foot massager?
To use FSA dollars, purchase a foot massager labeled as FSA eligible through a retailer that accepts FSA cards or provides an itemized receipt for reimbursement. Some massagers may require a letter of medical necessity (LMN) from your health care provider, so check with your FSA plan to confirm any additional documentation requirements.
Are FSA-approved foot massagers similar in quality to regular foot massagers?
Are FSA-approved foot massagers similar in quality to regular foot massagers?
FSA-approved foot massagers are often the same quality as regular foot massagers. The key difference lies in their eligibility for FSA spending, which requires the device to meet specific health-related criteria. Many high-quality brands design products that qualify for FSA approval, ensuring you get both therapeutic benefits and value.
For this article, we consulted the following experts to gain their professional insights.
Dr. Gregory Alvarez, podiatrist at Ankle & Foot Centers of America
Dr. Michael Nirenberg, clinical and forensic podiatrist at Friendly Footcare in Indiana CNN Underscored thoroughly tests all the products we cover and provides full transparency about how we test them. We have an experienced team of writers and editors who have many years of testing experience and ensure each article is carefully edited and products are properly vetted. Contributing editor Marissa Miller has 15 years of experience writing and reporting on all things health and well-being, and serves as a certified personal trainer with a specialization in orthopedic exercise. For this article, she consulted two board-certified podiatrists for their advice on selecting the best FSA-approved foot massagers.
Explore trending products
HigherDose Full-Spectrum Infrared Sauna
Sunlighten mPulse Aspire Smart
Tatdol Portable Home Steam Sauna Box
Maxxus Lifesauna Aspen 2-Person Infrared
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Ischemic Stroke Epidemiology Forecast Report 2025-2034: Patient Population, Unmet Needs, Disease Risk and Burden
The Ischemic Stroke Epidemiology Forecast Report 2025-2034 offers extensive analysis on prevalence trends and demographic influences of ischemic stroke globally. Covering eight key markets, it details risk factors, treatment options, and forecasts trends influenced by age, gender, and geography, optimizing understanding and intervention strategies. Dublin, June 11, 2025 (GLOBE NEWSWIRE) -- The "Ischemic Stroke Epidemiology Forecast 2025-2034" report has been added to the United States, over 795,000 individuals experience a stroke annually. Of these, approximately 87% are ischemic strokes, which occur when blood flow to the brain is obstructed. The likelihood of having an ischemic stroke varies across different racial and ethnic groups and rises with Stroke Epidemiology Forecast Report CoverageThis report delivers a comprehensive analysis of the condition's prevalence and associated demographic factors. It projects future incidence and prevalence trends across diverse population groups, considering key variables such as age, gender, and ischemic stroke type. The report highlights change in prevalence over time and offers data-driven forecasts based on influencing factors. Additionally, it provides an in-depth overview of the disease, along with historical and projected epidemiological data for eight key markets:The United States, United Kingdom, France, Italy, Spain, Germany, Japan, and OverviewThe epidemiology section of ischemic stroke provides insights into the patient pool, ranging from historical data to projected trends across eight major markets. The Research examines both current and future trends for ischemic stroke, referencing various studies. The report includes detailed data on the diagnosed patient pool, broken down by age groups and specific categories. Ischemic strokes, responsible for about 87% of all strokes, occur when blood flow to the brain is blocked. In 2020, the global prevalence of acute ischemic stroke was 68.16 million. Risk factors such as high blood pressure, obesity, diabetes, high cholesterol, and smoking contribute significantly to ischemic strokes. Additionally, disparities in stroke incidence and outcomes are observed across racial and ethnic groups, with non-Hispanic Black and Pacific Islander adults experiencing the highest stroke-related mortality rates. Treatment OverviewIschemic stroke is a medical emergency that requires immediate intervention to restore blood flow to the brain and prevent further damage. The main goals of treatment are to minimize brain injury, improve functional recovery, and prevent complications. The approach typically involves a combination of medications, surgical interventions, and rehabilitation strategies.1. ThrombolysisThrombolytic therapy, such as tissue plasminogen activator (tPA), is used to dissolve the blood clot obstructing blood flow. When administered within 3-4.5 hours of symptom onset, it can significantly improve outcomes by restoring blood flow and minimizing brain damage. However, it is not suitable for all patients due to potential risks, including bleeding.2. Mechanical ThrombectomyFor patients with large vessel occlusions, mechanical thrombectomy is a procedure used to physically remove the clot. Performed within 6-24 hours of symptom onset, it can restore blood flow to the brain and significantly improve outcomes. This treatment is often combined with thrombolysis for optimal results.3. Antiplatelet TherapyFollowing an ischemic stroke, antiplatelet drugs like aspirin are prescribed to prevent further clots from forming. These medications reduce the risk of recurrent strokes by inhibiting platelet aggregation and helping to maintain normal blood flow. Long-term antiplatelet therapy is commonly recommended after an initial stroke event.4. AnticoagulantsFor certain patients, particularly those with atrial fibrillation or other heart conditions, anticoagulants like warfarin or direct oral anticoagulants (DOACs) are prescribed to prevent the formation of new clots. These medications work by inhibiting clotting factors in the blood, thus lowering the risk of further ischemic events.5. Rehabilitation TherapyPost-stroke rehabilitation is critical for restoring lost functions and improving the quality of life. Depending on the severity of the stroke, therapy may include physical, occupational, and speech therapy. These therapies help patients regain mobility, improve speech and cognitive function, and enhance independence in daily AnalysisIschemic stroke is a leading cause of disability and death worldwide, significantly affecting the quality of life for survivors. The physical, emotional, and cognitive impairments following a stroke can be profound, with many individuals experiencing long-term disabilities, such as paralysis, speech difficulties, and memory loss. These impairments not only affect the individual's ability to perform daily tasks but also place a heavy burden on caregivers and healthcare systems. The financial costs of rehabilitation, ongoing medical care, and loss of productivity further exacerbate the societal impact, making ischemic stroke a major public health concern Epidemiology TrendsThe epidemiology of ischemic stroke has evolved over the years, with several notable trends emerging in different populations globally. These trends are shaped by factors such as age, lifestyle, and healthcare access, and are crucial for understanding the growing burden of this condition. As ischemic stroke remains a leading cause of morbidity and mortality, tracking its epidemiological patterns is vital for timely interventions and preventive measures. Below are five significant trends in the epidemiology of ischemic stroke:1. Rising Incidence in Older Adults One prominent trend is the increasing incidence of ischemic stroke in older populations. With advancing age, the risk factors for ischemic stroke - such as hypertension, diabetes, and atrial fibrillation - become more prevalent. As life expectancy increases globally, the number of elderly individuals at risk of ischemic stroke also rises. This trend is particularly notable in developed countries, where aging populations present challenges for healthcare systems. The incidence of ischemic stroke in those aged 65 and older is projected to continue to rise, contributing to the growing burden of the disease.2. Higher Stroke Incidence in Low- and Middle-Income Countries There is a marked rise in the incidence of ischemic stroke in low- and middle-income countries, driven by the transition to urban lifestyles and the increasing prevalence of risk factors such as obesity, smoking, and a sedentary lifestyle. Poor access to healthcare, limited awareness, and inadequate stroke prevention programs further exacerbate the situation. These regions are experiencing a double burden, where traditional infectious diseases coexist with a surge in non-communicable diseases like ischemic stroke. This rising incidence underscores the need for improved public health strategies focused on prevention and early intervention.3. Gender Disparities in Ischemic Stroke Gender plays a critical role in the epidemiology of ischemic stroke, with distinct differences in incidence, outcomes, and risk factors between men and women. Women, particularly those over 55, are at higher risk of ischemic stroke compared to men, with factors such as hormonal changes, pregnancy-related complications, and the use of oral contraceptives contributing to this disparity. Additionally, women tend to experience worse outcomes, including greater disability and a higher risk of recurrent strokes. Understanding these gender differences is essential for tailoring prevention and treatment strategies to different populations.4. Growing Prevalence of Risk Factors The prevalence of major risk factors for ischemic stroke, such as hypertension, diabetes, and high cholesterol, continues to rise globally. As urbanization and lifestyle changes lead to more sedentary habits and poorer diets, the number of individuals with these risk factors is steadily increasing. A significant trend is the growing awareness of hypertension as a key modifiable risk factor for ischemic stroke. However, despite awareness efforts, managing and controlling hypertension remains a challenge, especially in low- and middle-income countries. The rising prevalence of these risk factors is directly contributing to the increased incidence of ischemic stroke worldwide.5. Technological Advances and Improved Survival Rates Advances in medical technology and treatment options have led to improved survival rates following ischemic strokes. The use of thrombolytic therapy (clot-busting drugs) and mechanical thrombectomy for acute ischemic stroke has revolutionized stroke management, significantly reducing mortality and disability in some patients. However, access to these advanced treatments remains limited in certain regions, leading to disparities in outcomes. As healthcare systems worldwide invest in stroke care infrastructure, it is expected that survival rates will continue to improve, though challenges in accessibility will persist in underserved by RegionThe epidemiology of ischemic stroke varies across countries and regions due to differences in healthcare infrastructure, socioeconomic factors, cultural attitudes towards pain, and access to pain management therapies. Understanding these variations is essential for developing targeted interventions and improving patient regions include: The United States Germany France Italy Spain The United Kingdom Japan India These regions exhibit distinct epidemiological trends, reflecting the unique challenges and opportunities within their healthcare epidemiology of ischemic stroke differs greatly across countries, influenced by factors such as the prevalence of risk factors (hypertension, diabetes, smoking, obesity, and high cholesterol), healthcare infrastructure, lifestyle habits, and socioeconomic status. In the United Kingdom, approximately 100,000 people experience a stroke annually, with an estimated 85% of these cases being ischemic Questions Answered How do socioeconomic factors influence the prevalence and outcomes of ischemic strokes across different regions? What is the impact of genetic predisposition on the incidence of fibrocystic breast condition in various populations? How does access to healthcare services affect the early diagnosis and treatment of pneumonia in low-income countries? What role do environmental factors, such as air pollution, play in the rising rates of respiratory diseases like pneumonia? How does the aging population contribute to the increasing burden of ischemic stroke, particularly in developed nations? What differences in treatment outcomes are observed between patients with ischemic strokes from urban versus rural areas? How do lifestyle changes, such as diet and exercise, impact the incidence of conditions like ischemic stroke in different ethnic groups? What are the key demographic and epidemiological trends shaping the rise in chronic respiratory diseases worldwide? How does climate change influence the spread of infectious diseases like pneumonia, especially in vulnerable populations? What strategies have proven most effective in reducing the incidence of seasonal influenza in high-risk populations? Scope of the Report The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of ischemic stroke based on several factors. The ischemic stroke epidemiology forecast report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India) The report helps to identify the patient population, the unmet needs of ischemic stroke are highlighted along with an assessment of the disease's risk and burden. Key Topics Covered1 Preface1.1 Introduction1.2 Objectives of the Study1.3 Research Methodology and Assumptions2 Executive Summary3 Ischemic Stroke Market Overview - 8 MM3.1 Ischemic Stroke Market Historical Value (2018-2024)3.2 Ischemic Stroke Market Forecast Value (2025-2034)4 Ischemic Stroke Epidemiology Overview - 8 MM4.1 Ischemic Stroke Epidemiology Scenario (2018-2024)4.2 Ischemic Stroke Epidemiology Forecast5 Disease Overview5.1 Signs and Symptoms5.2 Causes5.3 Risk Factors5.4 Guidelines and Stages5.5 Pathophysiology5.6 Screening and Diagnosis5.7 Types of Ischemic Stroke6 Patient Profile6.1 Patient Profile Overview6.2 Patient Psychology and Emotional Impact Factors7 Epidemiology Scenario and Forecast - 8 MM7.1 Key Findings7.2 Assumptions and Rationale7.3 Ischemic Stroke Epidemiology Scenario in 8MM (2018-2034)8 Epidemiology Scenario and Forecast: United States8.1 Ischemic Stroke Epidemiology Scenario and Forecast in The United States (2018-2034)9 Epidemiology Scenario and Forecast: United Kingdom9.1 Ischemic Stroke Epidemiology Scenario and Forecast in United Kingdom (2018-2034)10 Epidemiology Scenario and Forecast: Germany10.1 Ischemic Stroke Epidemiology Scenario and Forecast in Germany (2018-2034)11 Epidemiology Scenario and Forecast: France11.1 Ischemic Stroke Epidemiology Scenario and Forecast in France12 Epidemiology Scenario and Forecast: Italy12.1 Ischemic Stroke Epidemiology Scenario and Forecast in Italy (2018-2034)13 Epidemiology Scenario and Forecast: Spain13.1 Ischemic Stroke Epidemiology Scenario and Forecast in Spain (2018-2034)14 Epidemiology Scenario and Forecast: Japan14.1 Ischemic Stroke Epidemiology Scenario and Forecast in Japan (2018-2034)15 Epidemiology Scenario and Forecast: India15.1 Ischemic Stroke Epidemiology Scenario and Forecast in India (2018-2034)16 Patient Journey17 Treatment Challenges and Unmet Needs18 Key Opinion Leaders (KOL) InsightsFor more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 hours ago
- Yahoo
Parents are dismayed after FDA rejects experimental drug 4-year-old girl relies on
A family thought they had a life-changing drug for their 4-year-old daughter. Then the FDA rejected it. Channel 2's Michael Doudna heard from the girl's parents. For Hope Filchak, her daily routine includes a daily shot to help provide a normal life. However, soon the drug may go away. 'It's scary to think she might not have this in just a few months,' Caroline Filchak, Hope's mother, said. [DOWNLOAD: Free WSB-TV News app for alerts as news breaks] Hope was born with a rare mitochondrial disease that impacts fewer than 100 people in the world. The impacts are wide-ranging and a challenge to overcome. 'From early on, it was an uphill battle for Hope,' Caroline Filchak said. 'I think she's got 12 specialists that we see in three different states.' 'It affects her brain, her heart, her eyes and her ears, deafness, blindness, and then two heart defects,' Ben Filchak, Hope's father, said. There are no FDA-approved drugs for Hope's condition. So when heart troubles arose in 2024, the family was forced to turn to an experimental drug, elemipretide, and saw immediate improvement. 'Her energy increased, and her heart function has stabilized completely,' Ben Fiilchak said. However, last month, the FDA declined to give it approval. 'I would say that the FDA is trying to regulate two things, right. They're trying to make sure the products are safe, including drugs, but also that they are efficacious for people,' said Rossana Sanchez Russo, an Emory clinical geneticist. According to the parent company producing the drug, the FDA's rejection was in part because the FDA did not see an improvement in a six-minute walk test. 'We all know in the field that a six-minute walk test is not the be-all end-all outcome measure for mitochondrial diseases,' Amy Goldstein, a leading mitochondrial disease expert, said. She says the drug showed improvement in areas such as quality of life and cardiac health. 'I myself personally saved a baby in my cardiac ICU with Barre syndrome. He went home with no cardiac manifestations after arriving here in severe heart failure and needing a heart transplant,' Goldstein said. 'We were extremely disappointed that based on all of the data, they made the decision not to approve the drug.' Another hurdle rare disease drug testing faces is sample size. By its very nature, only a few people have these diseases, so getting a meaningful sample during clinical trials can be difficult. 'Sometimes we don't have enough burden of proof to be able to formally say that. That doesn't mean that it may not be working for a family or that it might not work for other conditions. It may mean that we just do not have all the data,' Sanchez Russo said. The FDA says the company behind the drug can reapply for approval, but it is unclear if it will be successful and how long the company can stay committed to producing a drug without the FDA giving an OK. Hope's family has a four-month supply of the drug left. However, they do not know how much longer access to the medicine will last. 'Hope is a special little girl, and she means so much to our family,' Caroline Filchak said. TRENDING STORIES: Raids uncover largest fentanyl pill operation in state history in Atlanta, Douglasville Hurricane season starts quietly in the Atlantic They were once best friends, then one killed the other. We take you inside this bizarre murder case [SIGN UP: WSB-TV Daily Headlines Newsletter]


Business Upturn
10 hours ago
- Business Upturn
PlushCare Launches Enhanced Online Weight Loss Program to Expand National Access to GLP-1 Prescriptions Through Board-Certified Doctors
San Francisco, June 10, 2025 (GLOBE NEWSWIRE) — PlushCare, a leading virtual healthcare platform, has announced a significant upgrade to its online Weight Loss Program, enabling greater access to GLP-1-based prescription treatments such as semaglutide through board-certified physicians. This development marks a critical milestone in the company's mission to provide affordable, clinically supervised weight management across the United States. Accessible at the updated platform streamlines the process for eligible adults to consult with licensed physicians, receive lab work if necessary, and access customized treatment plans—all from the comfort of their homes. 'We're committed to making evidence-based weight loss solutions more accessible through modern telehealth,' said a PlushCare spokesperson. 'Our program is designed to connect people with experienced doctors who can evaluate eligibility for medications like GLP-1s and deliver a personalized plan that fits their health goals.' Expanded Features for 2025 The revamped Weight Loss Program now includes: Nationwide Access to medical providers via secure telehealth appointments to medical providers via secure telehealth appointments Eligibility Evaluation for FDA-approved medications, including semaglutide for FDA-approved medications, including semaglutide Personalized Plans tailored to each user's metabolic profile tailored to each user's metabolic profile Optional Lab Testing with integrated results for precision treatment with integrated results for precision treatment Transparent Pricing with no insurance required The platform is optimized for mobile and desktop users, offering a seamless experience from appointment scheduling to prescription delivery. Addressing a Growing National Health Concern According to the CDC, over 40% of U.S. adults struggle with obesity, with rising demand for effective clinical support. PlushCare's integrated virtual care model delivers a scalable solution that removes traditional geographic and scheduling barriers. Patients can typically get started in under 15 minutes by completing an intake form and booking a same-day appointment with a licensed doctor. If clinically appropriate, a prescription is sent to their preferred pharmacy. About PlushCare PlushCare is a virtual primary care and mental health platform that connects patients with top U.S. medical professionals through its secure telehealth platform. With a commitment to quality care, convenience, and evidence-based treatment, PlushCare is redefining access to modern healthcare. For more information, visit Media Contact:PlushCare Media Relations Email: [email protected] Website: Address: 345 California Street, Suite 600, San Francisco, CA 94105, United States